Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,296 papers from all fields of science
Search
Sign In
Create Free Account
Hematopoietic Stem Cell Mobilization
Known as:
Mobilization, Stem Cell
, Stem Cell Mobilization
, stem cell mobilisation
The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Apheresis (procedure)
Hemopoietic stem cell transplant
nursing therapy
standards characteristics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Advances in stem cell mobilization.
Ibraheem H. Motabi
,
J. Dipersio
Blood reviews
2012
Corpus ID: 36327549
Highly Cited
2011
Highly Cited
2011
First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor
F. Lefrère
,
A. Brignier
,
+7 authors
M. Cavazzana‐Calvo
Advances in Therapy
2011
Corpus ID: 35278793
IntroductionMobilization techniques for autologous peripheral blood stem cell (PBSC) collection include chemotherapy followed by…
Expand
Highly Cited
2008
Highly Cited
2008
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
R. Chaligné
,
C. Tonetti
,
+15 authors
S. Giraudier
Leukemia
2008
Corpus ID: 54604085
MPL (or thrombopoietin receptor, TPO-R) 515 mutations have recently been described in 5–10% of primitive myelofibrosis (PMF…
Expand
2006
2006
Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.
C. Steinwender
,
R. Hofmann
,
+6 authors
F. Leisch
American Heart Journal
2006
Corpus ID: 45190790
2006
2006
Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization
Pingfu Fu
,
Pingfu Fu
,
+18 authors
H. Lazarus
Bone Marrow Transplantation
2006
Corpus ID: 7045197
We examined pre-mobilization blood CD34+ cell count to predict ability to mobilize adequate peripheral blood progenitor cells…
Expand
Review
2000
Review
2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT…
Michallet
,
Thiébaut
,
+9 authors
Apperley
British Journal of Haematology
2000
Corpus ID: 22412025
We performed a survey from 122 centres of the European Group of Blood and Marrow Transplantation (EBMT) concerning peripheral…
Expand
Highly Cited
1999
Highly Cited
1999
Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
T. Watanabe
,
Y. Kawano
,
+8 authors
James E. Talmadge
Blood
1999
Corpus ID: 11505560
The relationship between stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) and the endogenous production…
Expand
Highly Cited
1999
Highly Cited
1999
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
R. Buckstein
,
K. Imrie
,
+9 authors
N. Berinstein
Seminars in Oncology
1999
Corpus ID: 38169717
The chimeric anti-CD20 monoclonal antibody rituximab (Rituxan; IDEC Pharmaceuticals, San Diego, CA, and Genentech, Inc, San…
Expand
Highly Cited
1999
Highly Cited
1999
Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens
D. Stewart
,
D. Guo
,
+9 authors
J. Russell
Bone Marrow Transplantation
1999
Corpus ID: 20915275
The study purpose was to determine if G-CSF plus dose-intensive cyclophosphamide 5.25 g/m2, etoposide 1.05 g/m2 and cisplatin 105…
Expand
Highly Cited
1999
Highly Cited
1999
Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome.
Joan García
,
M. Cicilano
,
+10 authors
T. Sprovieri
Haematologica
1999
Corpus ID: 23347968
BACKGROUND AND OBJECTIVE Hereditary hyperferritinemia-cataract syndrome (HHCS) is an autosomal dominant disorder characterized by…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE